The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Transition metal complexes as photosensitisers in one- and two-photon photodynamic therapy
Abstract
Abstract Photodynamic therapy (PDT) exploits light-activated compounds for therapeutic use. It relies on a photosensitiser (PS) that is inactive in the absence of light. When irradiated, the PS absorbs light and is promoted to a higher energy, “excited” state (PS∗), which is either toxic to cells in itself or triggers formation of other species which are toxic to cells, and hence particular wavelengths of light can be used to induce light-dependent cell killing. In PDT occurring via the so-called type I and type II mechanisms, the PS∗ engages in energy transfer to dioxygen present in cells and tissues. This process generates highly reactive singlet oxygen (1O2) and/or other reactive oxygen species (ROS), which in turn cause damage in the immediate vicinity of the irradiation and ultimately can lead to cell death. Whilst the main focus of research for the last 50 years has been on organic molecules or porphyrins as sensitisers, there is now emerging interest in extending the use to transition metal (TM) complexes, which can display intense absorptions in the visible region, and many also possess high two-photon absorption cross-sections, enabling two-photon excitation with NIR light. As with any other type of photosensitiser, the issues to consider whilst designing a TM complex as a photosensitiser include cell permeability, efficient absorption of NIR light for deeper penetration, preferential affinity to cancer cells over healthy cells, targeted intracellular localisation and lack of side effects. This review summarises recent developments involving photosensitisers containing Ru(II), Os(II), Pt, Ir(III), and Re(I) ions, and the approaches used to address the above requirements. Several remarkable recent advances made in this area, including the first clinical trial of a metal complex as a photosensitiser, indicate the bright future of this class of compounds in PDT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prier, C. K., Rankic, D. A., & MacMillan, D. W. C. (2013) · Chemical Reviews · doi:10.1021/cr300503r · Cited by 9,590
Photodynamic therapy for cancer
Dolmans, D. E. J. G. J., Fukumura, D., & Jain, R. K. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1071 · Cited by 6,758
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy
Bonnett, R. (1995) · Chemical Society Reviews · doi:10.1039/cs9952400019 · Cited by 2,039
New and emerging HDAC inhibitors for cancer treatment
West, A. C., & Johnstone, R. W. (2014) · Journal of Clinical Investigation · doi:10.1172/jci69738 · Cited by 1,404
Phosphorescent heavy-metal complexes for bioimaging
Zhao, Q., Huang, C., & Li, F. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00114g · Cited by 1,260
Shining Light on Photoredox Catalysis: Theory and Synthetic Applications
Tucker, J. W., & Stephenson, C. R. J. (2012) · The Journal of Organic Chemistry · doi:10.1021/jo202538x · Cited by 1,158
The physics, biophysics and technology of photodynamic therapy
Wilson, B. C., & Patterson, M. S. (2008) · Physics in Medicine and Biology · doi:10.1088/0031-9155/53/9/r01 · Cited by 1,006
Porphyrin-based photosensitizers for use in photodynamic therapy
Sternberg, E. D., Dolphin, D., & Brückner, C. (1998) · Tetrahedron · doi:10.1016/s0040-4020(98)00015-5 · Cited by 987
Dye Sensitizers for Photodynamic Therapy
Ormond, A., & Freeman, H. (2013) · Materials · doi:10.3390/ma6030817 · Cited by 847
Cited by
Recent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy
Pham, T. C., Nguyen, V.-N., Choi, Y., Lee, S., & Yoon, J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00381 · Cited by 1,813
Zhao, X., Liu, J., Fan, J., Chao, H., & Peng, X. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00173b · Cited by 1,270
Metals to combat antimicrobial resistance
Frei, A., Verderosa, A. D., Elliott, A. G., Zuegg, J., & Blaskovich, M. A. T. (2023) · Nature Reviews Chemistry · doi:10.1038/s41570-023-00463-4 · Cited by 638
Type I Photosensitizers Revitalizing Photodynamic Oncotherapy
Chen, D., Xu, Q., Wang, W., Shao, J., Huang, W., & Dong, X. (2021) · Small · doi:10.1002/smll.202006742 · Cited by 482
Classification of Metal-Based Drugs according to Their Mechanisms of Action
Boros, E., Dyson, P. J., & Gasser, G. (2020) · Chem · doi:10.1016/j.chempr.2019.10.013 · Cited by 437
Metal-based photosensitizers for photodynamic therapy: the future of multimodal oncology?
McFarland, S. A., Mandel, A., Dumoulin-White, R., & Gasser, G. (2020) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.10.004 · Cited by 347
Rationally designed ruthenium complexes for 1- and 2-photon photodynamic therapy
Karges, J., Kuang, S., Maschietto, F., Blacque, O., Ciofini, I., Chao, H., & Gasser, G. (2020) · Nature Communications · doi:10.1038/s41467-020-16993-0 · Cited by 284
Yuan, H., Han, Z., Chen, Y., Qi, F., Fang, H., Guo, Z., Zhang, S., & He, W. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202014959 · Cited by 282
Lee, L. C.-C., & Lo, K. K.-W. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c03437 · Cited by 279
Phototherapeutic anticancer strategies with first-row transition metal complexes: a critical review
Gourdon, L., Cariou, K., & Gasser, G. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00609f · Cited by 262
Metadata
- Authors
- McKenzie, L. K., Bryant, H. E., & Weinstein, J. A.
- Venue
- Coordination Chemistry Reviews
- Publisher
- Elsevier BV
- Published
- 2019-01
- Volume
- 379
- Pages
- 2-29
- ISSN
- 0010-8545 (ISSN-L)
- OpenAlex
- W2801902442
- Cited by
- 431
- References
- 97
- FWCI
- 26.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.